Ipca Laboratories Ltd
🇰🇪Kenya
- Country
- 🇰🇪Kenya
- Ownership
- Public
- Established
- 1949-01-01
- Employees
- 22.8K
- Market Cap
- $4.2B
- Website
- http://www.ipca.com
Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 50 mg
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-06-24
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT01884857
- Locations
- 🇮🇳
Cliantha Research Limited, Ahmedabad, Gujarat,, India
Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-06-24
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT01884896
- Locations
- 🇮🇳
Cliantha Research Limited, Ahmedabad, Gujarat, India
Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-06-24
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT01884909
- Locations
- 🇮🇳
Cliantha Research Limited, Ahmedabad, Gujarat, India
Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fed Condition
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-04-15
- Last Posted Date
- 2013-04-15
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT01831674
- Locations
- 🇮🇳
Veeda Clinical Research Pvt. Ltd., Ahmedabad, Gujarat, India
Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed Condition
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-04-15
- Last Posted Date
- 2013-04-15
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT01831687
- Locations
- 🇮🇳
Veeda Clinical Research Pvt. Ltd., Ahmedabad, Gujarat, India
Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-04-15
- Last Posted Date
- 2013-04-15
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT01831700
- Locations
- 🇮🇳
Accutest Research Lab (I) Pvt. Ltd., Ahmedabad, Gujarat, India
Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fasting Condition
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-04-15
- Last Posted Date
- 2013-04-15
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT01831661
- Locations
- 🇮🇳
Veeda Clinical Research Pvt. Ltd., Ahmedabad, Gujarat, India
Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fasting Condition
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-04-10
- Last Posted Date
- 2013-04-10
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT01827865
- Locations
- 🇮🇳
Veeda Clinical Research Pvt. Ltd., Ahmedabad, Gujarat, India
Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-04-10
- Last Posted Date
- 2013-04-10
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT01827878
- Locations
- 🇮🇳
Accutest Research Lab (I) Pvt. Ltd., Ahmedabad, Gujarat, India
Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fed Condition
- First Posted Date
- 2012-12-13
- Last Posted Date
- 2012-12-13
- Lead Sponsor
- IPCA Laboratories Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT01749228
- Locations
- 🇮🇳
Veeda Clinical Research Pvt. Ltd., Ahmedabad, Gujarat, India
© Copyright 2024. All Rights Reserved by MedPath